PubMed

Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.

Roguin A, Koch W, Kastrati A, Aronson D, Schomig A, Levy AP.

Diabetes Care. 2003 Sep;26(9):2628-31.PMID: 12941730 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.

Iijima R, Ndrepepa G, Mehilli J, Markwardt C, Bruskina O, Pache J, Ibrahim M, Schömig A, Kastrati A.

Am Heart J. 2007 Oct;154(4):688-93.PMID: 17892992 [PubMed - indexed for MEDLINE]Related articles

Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease.

Park DW, Hong MK, Suh IW, Hwang ES, Lee SW, Jeong YH, Kim YH, Lee CW, Kim JJ, Park SW, Park SJ.

Am J Cardiol. 2007 Mar 15;99(6):760-5. Epub 2007 Jan 22.PMID: 17350360 [PubMed - indexed for MEDLINE]Related articles

Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents.

Hoffmann R, Stellbrink E, Schröder J, Grawe A, Vogel G, Blindt R, Kelm M, Radke PW.

Am J Cardiol. 2007 Nov 1;100(9):1347-52. Epub 2007 Aug 9.PMID: 17950788 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.

Rana JS, Monraats PS, Zwinderman AH, de Maat MP, Kastelein JJ, Doevendans PA, de Winter RJ, Tio RA, Frants RR, van der Laarse A, van der Wall EE, Jukema JW; GENDER study.

Diabetes Care. 2005 Apr;28(4):873-7.PMID: 15793188 [PubMed - indexed for MEDLINE]Related articlesFree article

Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.

Rodriguez A, Rodríguez Alemparte M, Fernández Pereira C, Sampaolesi A, da Rocha Loures Bueno R, Vigo F, Obregón A, Palacios IF; LASMAL investigators.

Am J Med. 2005 Jul;118(7):743-51.PMID: 15989908 [PubMed - indexed for MEDLINE]Related articles

Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.

Al Suwaidi J, Holmes DR Jr, Salam AM, Lennon R, Berger PB.

Am Heart J. 2004 May;147(5):815-22.PMID: 15131536 [PubMed - indexed for MEDLINE]Related articles

Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.

Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, Sangiorgio P, Tarantino F, Geraci G, Castriota F, Tondi S, Saia F, Cooke RM, Guastaroba P, Grilli R, Marzocchi A, Maresta A.

Circulation. 2008 Feb 19;117(7):923-30. Epub 2008 Feb 4.PMID: 18250265 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.

Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ; SPIRIT III Investigators.

JAMA. 2008 Apr 23;299(16):1903-13.PMID: 18430909 [PubMed - indexed for MEDLINE]Related articlesFree article

C677T polymorphism of the methylenetetrahydrofolate reductase gene is a risk factor of adverse events after coronary revascularization.

Botto N, Andreassi MG, Rizza A, Berti S, Bevilacqua S, Federici C, Palmieri C, Glauber M, Biagini A.

Int J Cardiol. 2004 Sep;96(3):341-5.PMID: 15301885 [PubMed - indexed for MEDLINE]Related articles

Insulin-treated diabetes mellitus and predictors of mid-term clinical outcome after percutaneous coronary interventions with stent implantation.

Tarantini G, Briguori C, Stankovic G, Takagi T, Corvaja N, Di Mario C, Colombo A.

Ital Heart J. 2003 Dec;4(12):843-9.PMID: 14976848 [PubMed - indexed for MEDLINE]Related articles

Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.

Marcucci R, Paniccia R, Antonucci E, Gori AM, Fedi S, Giglioli C, Valente S, Prisco D, Abbate R, Gensini GF.

Am J Cardiol. 2006 Nov 1;98(9):1156-9. Epub 2006 Aug 31.PMID: 17056317 [PubMed - indexed for MEDLINE]Related articles

Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.

Milman U, Blum S, Shapira C, Aronson D, Miller-Lotan R, Anbinder Y, Alshiek J, Bennett L, Kostenko M, Landau M, Keidar S, Levy Y, Khemlin A, Radan A, Levy AP.

Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):341-7. Epub 2007 Nov 21.PMID: 18032779 [PubMed - indexed for MEDLINE]Related articlesFree article

Sustained increased risk of adverse cardiac events over 5 years after implantation of gold-coated coronary stents.

Pache J, Dibra A, Schaut C, Schühlen H, Dirschinger J, Mehilli J, Kastrati A, Schömig A.

Catheter Cardiovasc Interv. 2006 Nov;68(5):690-5.PMID: 17039510 [PubMed - indexed for MEDLINE]Related articles

The predictive value of exercise QRS duration changes for post-PTCA coronary events.

Efrati S, Cantor A, Goldfarb B, Ilia R.

Ann Noninvasive Electrocardiol. 2003 Jan;8(1):60-7.PMID: 12848815 [PubMed - indexed for MEDLINE]Related articles

Coronary blood flow assessment after successful angioplasty for acute myocardial infarction predicts the risk of long-term cardiac events.

Furber AP, Prunier F, Nguyen HC, Boulet S, Delépine S, Geslin P.

Circulation. 2004 Dec 7;110(23):3527-33. Epub 2004 Nov 22.PMID: 15557378 [PubMed - indexed for MEDLINE]Related articlesFree article

Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.

Reynen K, Köckeritz U, Kropp J, Wunderlich G, Knapp FF, Schmeisser A, Strasser RH.

Int J Cardiol. 2004 May;95(1):29-34.PMID: 15159034 [PubMed - indexed for MEDLINE]Related articles

Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.

Mehilli J, Kastrati A, Schühlen H, Dibra A, Dotzer F, von Beckerath N, Bollwein H, Pache J, Dirschinger J, Berger PP, Schömig A; Intracoronary Stenting and Antithrombotic Regimen: Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics (ISAR-SWEET) Study Investigators.

Circulation. 2004 Dec 14;110(24):3627-35. Epub 2004 Nov 7.PMID: 15531766 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.

Hausleiter J, Kastrati A, Mehilli J, Schühlen H, Pache J, Dotzer F, Glatthor C, Siebert S, Dirschinger J, Schömig A; ISAR-SMART-2 Investigators.

J Intern Med. 2004 Nov;256(5):388-97.PMID: 15485474 [PubMed - indexed for MEDLINE]Related articles

Inflection point of ascending aortic waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty.

Ueda H, Nakayama Y, Tsumura K, Yoshimaru K, Hayashi T, Yoshikawa J.

Am J Hypertens. 2002 Sep;15(9):823-6.PMID: 12219879 [PubMed - indexed for MEDLINE]Related articles